DK2460820T3 - PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger - Google Patents
PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger Download PDFInfo
- Publication number
- DK2460820T3 DK2460820T3 DK12155382.0T DK12155382T DK2460820T3 DK 2460820 T3 DK2460820 T3 DK 2460820T3 DK 12155382 T DK12155382 T DK 12155382T DK 2460820 T3 DK2460820 T3 DK 2460820T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- making
- methods
- pcv2 immunogenic
- pcv2
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14161—Methods of inactivation or attenuation
- C12N2710/14163—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64051004P | 2004-12-30 | 2004-12-30 | |
US11/034,797 US7833707B2 (en) | 2004-12-30 | 2005-01-13 | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US11/319,975 US7700285B1 (en) | 2005-12-29 | 2005-12-29 | PCV2 immunogenic compositions and methods of producing such compositions |
EP05856068.1A EP1833992B1 (en) | 2004-12-30 | 2005-12-29 | Pcv2 immunogenic compositions and methods of producing such compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2460820T3 true DK2460820T3 (da) | 2019-07-15 |
Family
ID=36615566
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12155378.8T DK2460817T3 (da) | 2004-12-30 | 2005-12-29 | Immunogene PCV2-sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger |
DK12155382.0T DK2460820T3 (da) | 2004-12-30 | 2005-12-29 | PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12155378.8T DK2460817T3 (da) | 2004-12-30 | 2005-12-29 | Immunogene PCV2-sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger |
Country Status (20)
Country | Link |
---|---|
US (8) | US7833707B2 (da) |
EP (4) | EP2460817B1 (da) |
JP (3) | JP5726395B2 (da) |
KR (5) | KR20130113544A (da) |
CN (2) | CN101180406B (da) |
AR (1) | AR051885A1 (da) |
AU (1) | AU2005321798B2 (da) |
BR (1) | BRPI0519783A2 (da) |
CA (1) | CA2592735C (da) |
CL (3) | CL2010000657A1 (da) |
DK (2) | DK2460817T3 (da) |
MX (1) | MX2007007983A (da) |
MY (3) | MY174830A (da) |
PL (2) | PL1833992T3 (da) |
PT (1) | PT1833992E (da) |
RU (1) | RU2435854C2 (da) |
SG (2) | SG192442A1 (da) |
TW (3) | TWI479021B (da) |
WO (1) | WO2006072065A2 (da) |
ZA (1) | ZA200706158B (da) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
PL2460820T3 (pl) | 2004-12-30 | 2019-09-30 | Boehringer Ingelheim Animal Health USA Inc. | Immunogenne kompozycje PCV2 stosowane w zapobieganiu infekcjom PCV2 |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
WO2007094893A2 (en) * | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
RU2488407C2 (ru) * | 2005-12-29 | 2013-07-27 | Берингер Ингельхайм Ветмедика, Инк. | Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций |
EP2099927A4 (en) * | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS |
US20100129397A1 (en) * | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
PL2094872T5 (pl) * | 2006-12-15 | 2020-10-05 | Boehringer Ingelheim Animal Health USA Inc. | Leczenie świń seropozytywnych wobec przeciwciała anty-pcv2 antygenem pcv2 |
EP1941903A1 (en) * | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) * | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
US8138318B2 (en) * | 2007-09-13 | 2012-03-20 | Abbott Laboratories | Hepatitis B pre-S2 nucleic acid |
AU2008347235A1 (en) * | 2007-12-31 | 2009-07-16 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 virus like particle with foreign amino acid insertion |
CA2712006A1 (en) | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
EP2254595A4 (en) * | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
KR101627879B1 (ko) * | 2008-06-25 | 2016-06-07 | 브라아쉬 바이오테크 엘엘씨 | 강화된 소마토스타틴 면역성을 위한 조성물 및 방법 |
CA2744348C (en) * | 2008-11-19 | 2017-02-14 | Laboratorio Avi-Mex, S.A. De C.V. | Recombinant inactivated viral vector vaccine |
TWI627281B (zh) * | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
KR20110090711A (ko) * | 2010-02-04 | 2011-08-10 | 녹십자수의약품(주) | 신규한 돼지 써코바이러스 타입 2 및 그의 용도 |
US9932372B2 (en) * | 2010-07-08 | 2018-04-03 | United Biomedical, Inc. | Designer peptide-based PCV2 vaccine |
CN101920012B (zh) * | 2010-07-22 | 2012-12-12 | 普莱柯生物工程股份有限公司 | 利用家蚕生物反应器生产猪圆环病毒2型重组衣壳蛋白亚单位疫苗的方法及其产品 |
CN102115755A (zh) * | 2010-10-11 | 2011-07-06 | 洛阳普莱柯生物工程有限公司 | 酵母表达猪圆环病毒2型orf2蛋白与亚单位疫苗 |
TWI670373B (zh) * | 2011-02-08 | 2019-09-01 | 淡馬錫生命科學實驗室有限公司 | 用於有效率地表面呈示抗原蛋白質之新穎表現匣 |
CN102183650A (zh) * | 2011-02-15 | 2011-09-14 | 武汉中博生物股份有限公司 | 猪圆环病毒2型elisa抗体检测试剂盒 |
CA2838984A1 (en) | 2011-06-10 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Methods for modulating kallikrein (klkb1) expression |
CN103102397A (zh) * | 2011-11-09 | 2013-05-15 | 韩健宝 | 预防和治疗pcv-2病毒的肽核酸及其制剂 |
UA113192C2 (xx) * | 2011-12-06 | 2016-12-26 | Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2) | |
CN102517331A (zh) * | 2011-12-26 | 2012-06-27 | 武汉中博生物股份有限公司 | 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用 |
CN103033622B (zh) * | 2011-12-26 | 2015-03-25 | 武汉中博生物股份有限公司 | 猪圆环病毒2型elisa抗原检测试剂盒及其制备方法和其应用 |
EA033354B1 (ru) * | 2012-01-13 | 2019-10-31 | Boehringer Ingelheim Vetmedica Gmbh | Набор для приготовления прививочного препарата |
US9474692B2 (en) | 2012-01-13 | 2016-10-25 | Boehringer Ingelheim Vetmedica Gmbh | Kit for the preparation of a vaccinating agent |
CN105026419B (zh) | 2013-03-01 | 2021-08-24 | 勃林格殷格翰动物保健美国有限公司 | 疫苗组合物定量 |
WO2014179200A1 (en) * | 2013-04-30 | 2014-11-06 | Boehringer Ingelheim Vetmedica, Inc. | Orf2 protein of pcv2 subtype a (pcv2a) for use in cross-protection |
ES2932410T3 (es) | 2013-08-23 | 2023-01-18 | Boehringer Ingelheim Animal Health Usa Inc | Vacuna de subunidad de circovirus porcino tipo 2 (PCV2) |
US9987348B2 (en) | 2013-09-25 | 2018-06-05 | Zoetis Services Llc | PCV2B divergent vaccine composition and methods of use |
CN105658660A (zh) | 2013-10-02 | 2016-06-08 | 勃林格殷格翰动物保健公司 | Pcv2 orf2蛋白变体和由其组成的病毒样颗粒 |
US10130698B2 (en) * | 2013-12-03 | 2018-11-20 | Intervet Inc. | Vaccine against porcine circo virus type 2 |
JP2014065741A (ja) * | 2014-01-09 | 2014-04-17 | Boehringer Ingelheim Vetmedica Inc | ブタのprdcの治療 |
TWI577802B (zh) * | 2014-08-01 | 2017-04-11 | 豐茂生物科技有限公司 | 胞外分泌型豬環狀病毒重組外殼蛋白類病毒顆粒(PCV2 Cap VLP),其製備方法及於次單位疫苗之應用 |
US9328147B2 (en) * | 2014-09-05 | 2016-05-03 | Chung Yuan Christian University | Recombinant baculovirus vector and uses thereof |
CN104388453B (zh) * | 2014-11-14 | 2017-03-22 | 华中农业大学 | 一种猪圆环病毒cap蛋白嵌合猪瘟病毒B细胞表位的重组病毒及应用 |
US10168330B2 (en) | 2015-03-05 | 2019-01-01 | Boehringer Ingelheim Vetmedica, Inc. | Marker system, in particular for baculovirus-expressed subunit antigens |
US10555994B2 (en) | 2015-03-30 | 2020-02-11 | Boehringer Ingelheim Animal Health USA Inc. | PCV2 ORF2 carrier platform |
JP6854781B2 (ja) | 2015-06-16 | 2021-04-07 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーBoehringer Ingelheim Vetmedica GmbH | 接続及び容器システム |
AU2016279560C1 (en) | 2015-06-16 | 2020-12-24 | Boehringer Ingelheim Vetmedica Gmbh | Connecting and container system |
UA125579C2 (uk) | 2015-06-16 | 2022-04-27 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Система ємностей і їх з'єднання |
CN105087606A (zh) * | 2015-09-23 | 2015-11-25 | 天津瑞普生物技术股份有限公司 | 猪圆环病毒2型cap抗原制备方法 |
JP7088835B2 (ja) | 2015-10-16 | 2022-06-21 | カンザス ステイト ユニバーシティ リサーチ ファウンデーション | ブタサーコウイルス3型免疫原性組成物、その製造方法、およびその使用方法 |
KR102669319B1 (ko) | 2016-11-03 | 2024-05-28 | 베링거잉겔하임베트메디카게엠베하 | 돼지 파보바이러스에 대한 백신 |
MX2019005136A (es) | 2016-11-03 | 2019-06-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta. |
AR110370A1 (es) | 2016-12-16 | 2019-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Sistema de recipientes y método |
CN107365362B (zh) * | 2017-07-04 | 2021-02-05 | 武汉科前生物股份有限公司 | 一种大规模生产高纯度猪圆环病毒orf2蛋白的方法 |
US10968026B2 (en) | 2017-07-11 | 2021-04-06 | Boehringer Ingelheim Vetmedica Gmbh | Container system |
BR112020002006A2 (pt) | 2017-08-03 | 2020-08-11 | Intervet International B.V. | vacina compreendendo uma proteína orf2 de pcv2 de genótipo 2b |
TWI762706B (zh) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
CN107982528A (zh) * | 2017-10-16 | 2018-05-04 | 北京生科基因科技有限公司 | Pcv2重组杆状病毒样颗粒亚单位疫苗及制备方法 |
PL3697804T3 (pl) * | 2017-10-17 | 2024-01-03 | Intervet International B.V. | Rekombinowana ekspresja białka orf2 pcv2b w komórkach owadzich |
CA3091982A1 (en) | 2018-03-26 | 2019-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Method of producing an immunogenic composition |
WO2020097226A1 (en) * | 2018-11-06 | 2020-05-14 | Kansas State University Research Foundation | Compositions for improving vaccine safety and efficacy and methods of use thereof |
WO2020206452A1 (en) | 2019-04-04 | 2020-10-08 | Boehringer Ingelheim Animal Health USA Inc. | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof |
BR112022013795A2 (pt) | 2020-02-18 | 2022-09-13 | Novo Nordisk As | Composição farmacêutica líquida, e, kit |
US20230241198A1 (en) | 2020-07-24 | 2023-08-03 | Boehringer Ingelheim Animal Health USA Inc. | Combination porcine vaccine |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US3479705A (en) | 1966-12-15 | 1969-11-25 | Miami Brick & Stone Inc Of Mia | Molding apparatus |
US5069901A (en) | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
AU638970B2 (en) | 1989-01-23 | 1993-07-15 | Auspharm International Limited | Vaccine composition |
US5202430A (en) | 1990-01-16 | 1993-04-13 | University Of Tennessee | Transmissible gastroenteritis virus genes |
WO1991018627A1 (en) | 1990-05-29 | 1991-12-12 | Smithkline Beecham Corporation | Swine pneumonia vaccine and method for the preparation thereof |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
GB9023111D0 (en) * | 1990-10-24 | 1990-12-05 | Wellcome Found | Expression system |
DK0555366T3 (da) | 1990-11-01 | 2000-08-28 | Univ Iowa State Res Found Inc | Fremgangsmåde til bakteriel svækkelse og vaccine |
US6042830A (en) * | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
US5580557A (en) * | 1991-10-09 | 1996-12-03 | Iowa State University Research Foundation, Inc. | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
BR9507717A (pt) | 1994-05-10 | 1997-09-23 | American Home Prod | Vacina brsv viva modificada aperfeiçoada |
US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
DK0835930T3 (da) * | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
US20060029617A1 (en) | 1997-10-03 | 2006-02-09 | Charreyre Catherine E | Porcine circovirus and Helicobacter combination vaccines and methods of use |
UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
US7192594B2 (en) | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
US7211379B2 (en) | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
US20040062775A1 (en) * | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
PT2363488E (pt) | 1997-12-11 | 2015-01-13 | Univ Belfast | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
WO1999045956A1 (en) * | 1998-03-13 | 1999-09-16 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
US6294176B1 (en) * | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
US6472193B1 (en) | 1998-11-19 | 2002-10-29 | Azwell Inc. | Recombinant lysophosphatidic acid phosphatase |
FR2789695B1 (fr) * | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
US6497883B1 (en) * | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
CA2376361A1 (en) | 1999-08-19 | 2001-03-01 | Genset S.A. | Prostate cancer-related gene 3 (pg-3) and biallelic markers thereof |
GB9921147D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
WO2001017556A1 (fr) | 1999-09-07 | 2001-03-15 | Shionogi & Co., Ltd. | Préparations vaccinales administrables par les muqueuses |
GB9921146D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US6656478B1 (en) | 1999-11-12 | 2003-12-02 | Samuel D. Charles | Cross-protective salmonella vaccines |
EP1248646B1 (en) | 1999-12-21 | 2008-02-13 | Merial | Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
US6808900B2 (en) | 2000-06-15 | 2004-10-26 | Manitoba, University Of | Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
WO2001096377A2 (en) | 2000-06-15 | 2001-12-20 | Purdue Research Foundation | Vaccine for congenital tremors in pigs |
US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
JP2002247979A (ja) * | 2001-02-23 | 2002-09-03 | Nippon Biologicals Inc | マレック病ワクチンおよびその製造方法 |
EP1379671B1 (en) * | 2001-03-27 | 2009-05-06 | University of Saskatchewan | Methods to culture circovirus |
US20030096377A1 (en) | 2001-06-28 | 2003-05-22 | Virginia Tech Intellectual Properties, Inc. | Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2 |
JP2005515162A (ja) | 2001-07-02 | 2005-05-26 | ファイザー・プロダクツ・インク | マイコプラズマ・ハイオニューモニエ(Mycoplasmahyopneumoniae)を用いた単回ワクチン接種 |
US7361352B2 (en) | 2001-08-15 | 2008-04-22 | Acambis, Inc. | Influenza immunogen and vaccine |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
US20030199581A1 (en) | 2002-03-13 | 2003-10-23 | Seligson Allen L. | Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses |
US20030215455A1 (en) | 2002-05-14 | 2003-11-20 | Bailey Reynolds | Vaccine stabilizer and method of use |
US7335362B2 (en) * | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
US7223207B1 (en) * | 2002-09-13 | 2007-05-29 | Simon Basyuk | Exercise and massage device |
AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
WO2004069184A2 (en) | 2003-02-03 | 2004-08-19 | Cerebus Biologicals, Inc. | Methods for treating, preventing and detecting helicobacter infection |
US7563449B2 (en) | 2003-04-21 | 2009-07-21 | Pfizer Inc, | Methods for reducing cattle reproductive diseases |
CN1458167A (zh) * | 2003-06-02 | 2003-11-26 | 中国农业科学院哈尔滨兽医研究所 | 截短表达的猪圆环病毒ⅱ型衣壳蛋白抗原及其应用 |
US7335361B2 (en) | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
CA2533581C (en) | 2003-07-24 | 2012-05-08 | Merial Limited | Vaccine formulations comprising an oil-in-water emulsion |
PT1651260E (pt) | 2003-07-25 | 2009-09-24 | Boehringer Ingelheim Vetmed | Lawsonia intracellularis de origem europeia e vacinas, agentes de diagnóstico e métodos para sua utilização |
FR2861731B1 (fr) | 2003-10-30 | 2006-02-24 | Centre Nat Rech Scient | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
WO2005112995A1 (en) | 2004-04-26 | 2005-12-01 | Choongang Vaccine Laboratory Co., Ltd. | Inactivated mixed vaccine for porcine respiratory disease and the method of manufacturing thereof |
CN1579553A (zh) | 2004-05-18 | 2005-02-16 | 浙江大学 | Ii型猪圆环病毒核酸疫苗的制备方法及其应用 |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7700285B1 (en) * | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
US7300785B2 (en) * | 2005-02-03 | 2007-11-27 | Universiteit Ghent | Culturing circular ssDNA viruses for the production of vaccines |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
JP5408998B2 (ja) * | 2005-04-13 | 2014-02-05 | メリアル リミテッド | ブタサーコウイルス産生アッセイ |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
UA95458C2 (ru) | 2005-09-09 | 2011-08-10 | Интервет Интернешонал Б.В. | Вакцина против pcv-2 у mda-положительных поросят |
RU2488407C2 (ru) | 2005-12-29 | 2013-07-27 | Берингер Ингельхайм Ветмедика, Инк. | Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций |
WO2007094893A2 (en) | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
EP2099927A4 (en) | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS |
PL2094872T5 (pl) | 2006-12-15 | 2020-10-05 | Boehringer Ingelheim Animal Health USA Inc. | Leczenie świń seropozytywnych wobec przeciwciała anty-pcv2 antygenem pcv2 |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
GB0712160D0 (en) | 2007-06-22 | 2007-08-01 | Univ Ghent | Methods and compositions in the treatment of procine circoviral infection |
US20090017064A1 (en) | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
EP2254595A4 (en) | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
PT2547770T (pt) | 2010-03-16 | 2020-03-04 | Virginia Tech Intellectual Properties Inc | Vacina contra circovirus suíno, quimérica, atenuada, viva |
CN103122352B (zh) | 2012-09-27 | 2015-02-11 | 华中农业大学 | 一种猪圆环病毒2型重组杆状病毒及制备方法和应用 |
-
2005
- 2005-01-13 US US11/034,797 patent/US7833707B2/en active Active
- 2005-12-29 MY MYPI2013001951A patent/MY174830A/en unknown
- 2005-12-29 EP EP12155378.8A patent/EP2460817B1/en not_active Revoked
- 2005-12-29 RU RU2007128943/10A patent/RU2435854C2/ru active
- 2005-12-29 BR BRPI0519783-0A patent/BRPI0519783A2/pt active IP Right Grant
- 2005-12-29 KR KR1020137026195A patent/KR20130113544A/ko not_active Application Discontinuation
- 2005-12-29 KR KR1020147025900A patent/KR101629360B1/ko active IP Right Grant
- 2005-12-29 EP EP10174465.4A patent/EP2281829B1/en not_active Revoked
- 2005-12-29 SG SG2013049853A patent/SG192442A1/en unknown
- 2005-12-29 CN CN2005800477414A patent/CN101180406B/zh active Active
- 2005-12-29 KR KR1020137003087A patent/KR20130024978A/ko not_active Application Discontinuation
- 2005-12-29 CN CN201710520864.XA patent/CN107602671B/zh active Active
- 2005-12-29 MY MYPI2011006322A patent/MY172287A/en unknown
- 2005-12-29 PL PL05856068T patent/PL1833992T3/pl unknown
- 2005-12-29 KR KR1020077017350A patent/KR20080005911A/ko active Search and Examination
- 2005-12-29 CA CA2592735A patent/CA2592735C/en active Active
- 2005-12-29 TW TW101109225A patent/TWI479021B/zh active
- 2005-12-29 DK DK12155378.8T patent/DK2460817T3/da active
- 2005-12-29 PT PT58560681T patent/PT1833992E/pt unknown
- 2005-12-29 TW TW094147420A patent/TWI387647B/zh active
- 2005-12-29 MX MX2007007983A patent/MX2007007983A/es active IP Right Grant
- 2005-12-29 EP EP12155376.2A patent/EP2460816A3/en not_active Withdrawn
- 2005-12-29 DK DK12155382.0T patent/DK2460820T3/da active
- 2005-12-29 MY MYPI20056272A patent/MY147801A/en unknown
- 2005-12-29 EP EP05856068.1A patent/EP1833992B1/en active Active
- 2005-12-29 AR ARP050105616A patent/AR051885A1/es active Pending
- 2005-12-29 AU AU2005321798A patent/AU2005321798B2/en active Active
- 2005-12-29 ZA ZA200706158A patent/ZA200706158B/xx unknown
- 2005-12-29 PL PL10174465T patent/PL2281829T3/pl unknown
- 2005-12-29 KR KR1020157018364A patent/KR101798838B1/ko active IP Right Grant
- 2005-12-29 JP JP2007549685A patent/JP5726395B2/ja active Active
- 2005-12-29 SG SG200908713-1A patent/SG158188A1/en unknown
- 2005-12-29 TW TW103142506A patent/TWI582231B/zh active
- 2005-12-29 WO PCT/US2005/047596 patent/WO2006072065A2/en active Application Filing
-
2008
- 2008-06-12 US US12/137,960 patent/US7829101B2/en active Active
- 2008-06-12 US US12/138,020 patent/US7910306B2/en active Active
- 2008-06-12 US US12/137,909 patent/US8025888B2/en active Active
- 2008-06-12 US US12/137,938 patent/US20090022750A1/en not_active Abandoned
- 2008-06-12 US US12/137,950 patent/US20090022751A1/en not_active Abandoned
-
2010
- 2010-06-18 CL CL2010000657A patent/CL2010000657A1/es unknown
- 2010-10-19 CL CL2010001146A patent/CL2010001146A1/es unknown
-
2011
- 2011-07-25 US US13/190,452 patent/US20110274710A1/en not_active Abandoned
- 2011-09-29 JP JP2011214237A patent/JP5701191B2/ja active Active
-
2012
- 2012-08-31 CL CL2012002431A patent/CL2012002431A1/es unknown
- 2012-12-27 US US13/728,228 patent/US9011872B2/en active Active
-
2015
- 2015-01-26 JP JP2015012112A patent/JP2015091264A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2460820T3 (da) | PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger | |
FR22C1008I2 (fr) | Composition immunogène | |
DK3320919T3 (da) | Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille sådanne sammensætninger | |
DK2253644T3 (da) | Sammensætninger og fremgangsmåder til fremstilling af en sammensætning | |
NO20200670A1 (no) | Sammensetninger og fremgangsmåter for modulering av hemostase | |
DK1765327T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
DK2001611T3 (da) | Fremgangsmåde og sammensætning til oprensning af jord | |
DK1948695T3 (da) | Immunogene sammensætninger og fremgangsmåder til andvendelse | |
DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
DK3308788T3 (da) | Sammensætninger og fremgangsmåder til modulering af smn2-splejsning | |
DK1638999T3 (da) | Sammensætninger og fremgangsmåder til øgning af knoglemineralisering | |
MA28994B1 (fr) | Composition immunogene | |
DK1791791T3 (da) | Fremgangsmåder og sammensætninger til behandling af vand | |
DK2203478T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antistoffer mod sclerostin | |
DK2260862T3 (da) | Sammensætninger og fremgangsmåder til behandling af tumorer der præsenterer survivin-antigener | |
DK1891208T3 (da) | Hidtil ukendte cellulære sammensætninger og fremgangsmåder til fremstilling deraf | |
DK2087002T3 (da) | Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat | |
DK3207941T3 (da) | Fremgangsmåder og sammensætninger på basis af diphtheritoksin-interleukin-3-konjugater | |
DK2135603T3 (da) | Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet | |
DK2101819T3 (da) | Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis | |
DK1774566T3 (da) | Sammensætninger til afgivelse af kviksölv og fremgangsmåde til fremstilling deraf | |
DK2141204T3 (da) | Fremgangsmåde til fremstilling af bituminøse sammensætninger | |
DK1852430T3 (da) | Fremgangsmåde til fremstilling af proanthocyanidinoligomer | |
DK1951864T3 (da) | Sammensætninger og fremgangsmåder til reparation af vaskulær skade | |
DK1817055T3 (da) | Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf |